BREAKING
MAJOR78
APPROVALLimited grounding
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug - NDTV
Dr. Reddy's has received approval to sell a generic version of semaglutide (Ozempic), a popular weight-loss and diabetes drug. The article indicates pricing information for this generic option will be available, potentially offering a lower-cost alternative to the brand-name version.
Analysis
Generic semaglutide entry from Dr Reddy's threatens Novo Nordisk's Ozempic franchise in markets where patent protection has lapsed, accelerating pricing pressure on the GLP-1 leader.
- Dr Reddy's received approval to sell a generic version of semaglutide (Ozempic)
- Generic launch positioned as lower-cost alternative to brand-name Ozempic
Semaglutide News4d
Read